93,850 Shares in Sanofi $SNY Acquired by Leuthold Group LLC

Leuthold Group LLC purchased a new position in shares of Sanofi (NASDAQ:SNY) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 93,850 shares of the company’s stock, valued at approximately $4,548,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Flagship Harbor Advisors LLC bought a new stake in shares of Sanofi during the fourth quarter worth approximately $25,000. Measured Wealth Private Client Group LLC acquired a new position in Sanofi during the third quarter valued at approximately $29,000. Palisade Asset Management LLC acquired a new position in Sanofi during the third quarter valued at approximately $30,000. First Horizon Corp acquired a new position in Sanofi during the third quarter valued at approximately $33,000. Finally, Sittner & Nelson LLC acquired a new position in Sanofi during the third quarter valued at approximately $47,000. 14.03% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

SNY has been the subject of several research analyst reports. Weiss Ratings upgraded shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Wall Street Zen cut shares of Sanofi from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 21st. Bank of America cut shares of Sanofi from a “buy” rating to a “neutral” rating in a report on Thursday, February 12th. Citigroup restated a “neutral” rating on shares of Sanofi in a report on Monday, April 13th. Finally, Morgan Stanley set a $52.00 target price on shares of Sanofi in a report on Friday, May 1st. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, Sanofi presently has an average rating of “Hold” and an average price target of $51.00.

Sanofi Stock Performance

NASDAQ SNY opened at $42.69 on Friday. The company has a current ratio of 1.01, a quick ratio of 0.22 and a debt-to-equity ratio of 0.17. The firm’s fifty day moving average price is $45.60 and its two-hundred day moving average price is $47.46. Sanofi has a 1 year low of $42.33 and a 1 year high of $53.36. The firm has a market capitalization of $104.12 billion, a P/E ratio of 11.92, a price-to-earnings-growth ratio of 1.05 and a beta of 0.35.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th will be given a $2.4225 dividend. The ex-dividend date of this dividend is Monday, May 4th. This is a boost from Sanofi’s previous annual dividend of $2.04. This represents a dividend yield of 559.0%. Sanofi’s payout ratio is currently 49.44%.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.